APA (7th ed.) Citation

I, H., M, O., JJ, C., J, O., Group, D. B. C. C., Højris, I., . . . Overgaard, J. (1999). Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet, 354(9188), 1425. https://doi.org/10.1016/s0140-6736(99)02245-x

Chicago Style (17th ed.) Citation

I, Højris, Overgaard M, Christensen JJ, Overgaard J, Danish Breast Cancer Cooperative Group, I. Højris, M. Overgaard, J J. Christensen, and J. Overgaard. "Morbidity and Mortality of Ischaemic Heart Disease in High-risk Breast-cancer Patients After Adjuvant Postmastectomy Systemic Treatment with or Without Radiotherapy: Analysis of DBCG 82b and 82c Randomised Trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group." Lancet 354, no. 9188 (1999): 1425. https://doi.org/10.1016/s0140-6736(99)02245-x.

MLA (9th ed.) Citation

I, Højris, et al. "Morbidity and Mortality of Ischaemic Heart Disease in High-risk Breast-cancer Patients After Adjuvant Postmastectomy Systemic Treatment with or Without Radiotherapy: Analysis of DBCG 82b and 82c Randomised Trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group." Lancet, vol. 354, no. 9188, 1999, p. 1425, https://doi.org/10.1016/s0140-6736(99)02245-x.